SPON2 and pulmonary arterial hypertension: Additionally, no difference was observed in either ADAMTS13 (p = 0.22), tissue factor (p = 0.22) or spondin-2 (p = 0.44) before versus after treatment initiation in patients with PAH (Table 2).